Molecular study of Apolipoprotein E gene in familial hypercholesterolemic families

Nasir Ali, Sajid Naeem, Suliman Qadir Afridi, Akhtar Ali

Abstract


Abstract

Background: Familial hypercholesterolemia (FH) is understood to be one in all the foremost common hereditary disease and critically associated with Coronary heart condition worldwide. FH is taken into account to be caused because of mutations and polymorphisms within the apolipoprotein E (Apo E) cistron. Exaggerated level of density compound protein LDL-C is that the hallmark of this malady.

Methodology: Seven hypercholesterolemic families were chosen for this study. Case history was taken and pedigree was created in person by visiting every family. Exon3 and exon4 regions of ApoE cistron were amplified using polymerase chain reaction (PCR).After successful amplification, both citrons were sequenced. Single strand conformation polymorphism (SSCP) results were obtained to support the different pattern of single strand polymorphism of studied samples.

Results: The sequencing results of probands from all the seven families showed that six out of seven have Apo E three isoform whereas one family showed change within the sequence from T to C at 112 sequence position of processed macromolecule resulted in amino acid that represents it as Apo E4 isoform.

Conclusion: Our findings show that Apo E3 is more prevalent than Apo E4 and other isoforms in studied population of Pakistan.


Full Text:

PDF

References


Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease Consensus Statement of the European Atherosclerosis Society. European heart journal, (2013).

Goldstein JL, Brown MS. The LDL receptor. Arteriosclerosis, thrombosis, and vascular biology, (2009); 29(4): 431-438.

Fahed AC, Nemer GM. Familial hypercholesterolemia: the lipids or the genes? Nutrition & Metabolism, (2011); 8(1): 23.

Marks D, Thorogood M, Neil HAW, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis, (2003); 168(1): 1-14.

Hopkins PN. Familial hypercholesterolemia—improving treatment and meeting guidelines. International Journal of Cardiology, (2003); 89(1): 13-23.

Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Human Mutation, (1992); 1(6): 445-466.

Ahmad M, Afzal S, Malik IA, Mushtaq S, Mubarik A. An autopsy study of sudden cardiac death. JOURNAL-PAKISTAN MEDICAL ASSOCIATION, (2005); 55(4): 149.

Sambrook J, Russell DW. Rapid isolation of mammalian DNA. Cold Spring Harbor Protocols, (2006); 2006(1): pdb. prot3514.

Rozen S, Skaletsky H (1999) Primer3 on the WWW for general users and for biologist programmers. Bioinformatics methods and protocols: Springer. pp. 365-386.

Seet WT, Mary Anne TJA, Yen TS. Apolipoprotein E genotyping in the Malay, Chinese and Indian ethnic groups in Malaysia—a study on the distribution of the different apoE alleles and genotypes. Clinica Chimica Acta, (2004); 340(1): 201-205.

Mahfouz RA, Sabbagh AS, Zahed LF, Mahfoud ZR, Kalmoni RF, et al. Apolipoprotein E gene polymorphism and allele frequencies in the Lebanese population. Molecular Biology Reports, (2006); 33(2): 145-149.

Almawi W, Hassan G, Habbal MZ. Apolipoprotein E polymorphism in a healthy Lebanese population. Medical Principles and Practice, (1999); 8(2): 105-110.




DOI: http://dx.doi.org/10.62940/als.v1i1.38

Refbacks

  • There are currently no refbacks.